Write in a clean editor, then format for The Journal of Headache and Pain in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The Journal of Headache and Pain is a peer-reviewed journal published by BMC (BioMed Central), covering Migraine and Headache Studies, Trigeminal Neuralgia and Treatments, Neurological Complications and Syndromes. Over its lifetime it has published 4,118 papers, which have received 102,629 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. The Journal of Headache and Pain. 2023;12(3):45–58.
Formats any DOI in The Journal of Headache and Pain style. No sign-up. |
| Publishes research in | Migraine and Headache Studies Trigeminal Neuralgia and Treatments Neurological Complications and Syndromes Sympathectomy and Hyperhidrosis Treatments Traumatic Brain Injury Research |
| ISSN | 1129-2369 |
| Citation impact (2-yr) | 7.03 |
| h-index | 129 |
| i10-index | 1,970 |
| Article processing charge | $2,686 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Sapienza University of Rome |
| Journal website | thejournalofheadacheandpain.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: According to the Global Burden of Disease (GBD) study, headache disorders are among the most prevalent and disabling conditions worldwide. GBD builds on epidemiological studies (published and unpublished) which are notable for wide variations in both their methodologies and their prevalence estimates. Our first aim was to update the documentation of headache epidemiological studies,…
The main aim of the present study was to do an update on studies on headache epidemiology as a preparation for the multinational European study on the prevalence and burden of headache and investigate the impact of different methodological issues on the results. The study was based on a previous study, and a systematic literature…
BACKGROUND: A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway to prevent migraine. Since then, randomized controlled trials (RCTs) and real-world evidence have expanded the evidence and knowledge for those treatments. Therefore, the EHF panel decided to provide an updated guideline on the use…
This overview of the published epidemiological evidence of migraine helps to identify the size of the public-health problem that migraine represents. It also highlights the need for further epidemiological studies in many parts of the world to gain full understanding of the scale of clinical, economic and humanistic burdens attributable to it. This paper presents…
